|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.840 USD | +10.66% |
|
+31.51% | +91.04% |
| 07-29 | TD Cowen Initiates Opus Genetics at Buy | MT |
| 07-09 | Opus Genetics Provides Update On OPGx-BEST1 Program With Detailed Timeline For OPGx-BEST1 Results | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 287M | - | - | - | ||
| 1,079B | |||||
| 640B | |||||
| 465B | |||||
| 353B | |||||
| 301B |
- Stock Market
- Stocks
- IRD Stock
- Charts Opus Genetics, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
